Chidamide is a targeted drug indicated for the treatment of relapsed or refractory peripheral T-cell lymphoma (PTCL). Its common adverse reactions mainly include hematological abnormalities, gastrointestinal reactions, fatigue and an increased risk of infection, with the specific manifestations and severity varying from person to person. The drug must be administered strictly in accordance with medical advice, and regular monitoring is required.
Major Adverse Reactions and Corresponding Management Measures
Hematological Effects
Thrombocytopenia: It may increase the risk of bleeding. Regular complete blood count (CBC) monitoring is necessary, and dose adjustment or blood transfusion should be implemented when indicated.
Leukopenia: It elevates the risk of infection. Avoid crowded places and seek prompt medical attention if symptoms such as fever develop.
Anemia: It presents with fatigue and dizziness, which can be improved with medication or dietary adjustments.
Gastrointestinal Reactions
Nausea and vomiting: Relief can be achieved through fractional meals and the administration of antiemetics.
Diarrhea: Maintain adequate fluid intake; medical intervention is required in severe cases.
Systemic Symptoms
Fatigue: Rational rest scheduling is recommended, and overexertion should be avoided.
Anorexia: Adopt a pattern of small, frequent meals and choose foods with high nutritional density.
Other Potential Risks
Elevated infection risk: Avoid contact with infection sources and conduct regular immune function tests.
Hepatic dysfunction: Monitor transaminase levels and initiate hepatoprotective therapy when necessary.
Precautions for Medication
Strictly follow medical advice
Dose adjustment or drug discontinuation must be evaluated by a physician, and no arbitrary decisions shall be made by patients themselves.
Undergo regular reexaminations
Include tests such as complete blood count and liver and kidney function assessments to detect abnormalities at an early stage.
Seek prompt medical attention
Immediate contact with a physician is required if severe bleeding, persistent high fever, dyspnea and other severe symptoms occur.
Chidamide is a prescription drug, and its use must be based on the evaluation and guidance of a professional physician. Close communication with the medical team is essential during treatment, and an individualized monitoring plan should be formulated according to personal conditions to ensure the safety and efficacy of medication administration.
